Statute treatment: 28 U.S.C. § 1407

Ranked leading cases interpreting this statute, drawn from 8,147 citation events across 4,826 distinct cases.

8,147citations total

4,826distinct interpreting cases

140distinct courts

1,361citations in last 5y

1968–2026year range

Top 20 leading cases

#1 In Re Equity Funding Corp. of America Securities Litigation (1974) jpml 63 own cites 14× in case

#2 In Re KOREAN AIR LINES DISASTER OF SEPTEMBER 1, 1983. Appeal of Plaintiffs Steering Committee (1987) cadc 306 own cites 7× in case

#3 In Re: Joann Patenaudepetitioners (2000) ca3 172 own cites 8× in case

#4 Ocwen Loan Servicing, LLC v. Washington (2006) ala 35 own cites 16× in case

#5 United States Ex Rel. Pogue v. Diabetes Treatment Centers of America, Inc. (2002) dcd 68 own cites 11× in case

#6 In Re United Mine Workers of America Employee Benefit Plans Litigation (1994) dcd 261 own cites 6× in case

#7 In Re: Rolls Royce Corporation (2014) ca5 155 own cites 7× in case

#8 In Re National Student Marketing Litigation (1973) jpml 15 own cites 22× in case

#9 Lexecon Inc. v. Milberg Weiss Bershad Hynes & Lerach (1998) scotus 662 own cites 4× in case

#10 In Re Equity Funding Corp. of America Securities Litigation (1976) cacd 86 own cites 7× in case

#11 In re Best Buy Co. (2011) jpml 117 own cites 6× in case

#12 Pharmacy Benefit Managers Antitrust Litigation (2009) ca3 104 own cites 6× in case

#13 In Re Corrugated Container Antitrust Litigation-John W. Culy (1981) cadc 66 own cites 7× in case

#14 In Re Republic National-Realty Equities Securities Litigation (1974) jpml 49 own cites 7× in case

#15 Kehr Ex Rel. Kehr v. Yamaha Motor Corp., USA (2008) nysd 334 own cites 3× in case

#16 In Re Brand-Name Prescription Drugs Antitrust Litigation (2003) jpml 42 own cites 7× in case

#17 Freedman v. Amalgamated Sugar Co. (1976) paed 117 own cites 4× in case

#18 In Re Diet Drugs (2009) ca3 108 own cites 4× in case

#19 In Re Integrated Resources Real Estate Ltd. Partnerships Securities Litigation (1993) nysd 107 own cites 4× in case

#20 In Re American Medical Systems, Inc. Pfizer, Inc. (1996) ca6 745 own cites 2× in case

Ranking method: leading_score = ln(1 + own_citation_count) × √(mentions_in_case) × flag_factor, where flag_factor = 1.0 green · 0.6 unknown · 0.5 neutral · 0.4 yellow · 0.3 procedural · 0 red. Red-flagged cases excluded — their interpretation has been undermined and shouldn't lead the list. Top 20 returned per statute. Open any case for full G Cite, trajectory, and per-circuit treatment.